CC
ATRC icon

Centiva Capital’s AtriCure ATRC Stock Holding History

Centiva Capital’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-16,687
Closed -$510K – 1554
2024
Q4 		$510K Buy
+16,687
New +$537K 0.01% 811
2024
Q3 		– Sell
-10,959
Closed -$250K – 2125
2024
Q2 		$250K Buy
+10,959
New +$253K ﹤0.01% 1563

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Centiva Capital's ATRC Position: Q1 2025 in Review

Centiva Capital sold out of AtriCure (ATRC) in Q1 2025, closing a stake of 16,687 shares — an estimated $510K sold.

Centiva Capital first reported a position in ATRC in Q2 2024 and held it in 2 quarters. The position peaked at $510K in Q4 2024. 221 funds tracked by Wall St. Rank hold ATRC as of Q1 2025.

  • Centiva Capital reported no remaining AtriCure position as of Q1 2025 after selling out during the quarter.
  • Centiva Capital sold 16,687 AtriCure shares in Q1 2025, an estimated $510K.
  • Centiva Capital first reported a position in AtriCure in Q2 2024 and held it in 2 quarters.
  • Centiva Capital's AtriCure position peaked at $510K in Q4 2024.
  • 221 funds tracked by Wall St. Rank held AtriCure as of Q1 2025.

Based on Centiva Capital's 13F filing for Q1 2025, filed 15 May 2025.